Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Chemotherapy and long-term outcome compared between lobular and ductal disease
January 27th, 2005
Response to primary chemotherapy isn't as positive in cases of invasive lobular carcinoma as in invasive ductal carcinoma, but long-term outcomes are better, indicate study data. M. Cristofanilli, of the University of Texas M.D. Anderson Cancer Center, and colleagues studied "the impact of histologic type invasive lobular carcinoma (ILC) versus invasive ductal carcinoma (IDC) on response to primary chemotherapy (PC) and long-term outcome." They worked with 1,034 patients with stage II and III breast cancer who participated in 6 clinical trials of PC at [the M.D. Anderson Cancer Center] between 1985 and 2002. One hundred twenty-two patients (12%) had...
Source: Women's Health Weekly (2005-01-27)
|
